| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $1.87B | $1.77B | $1.94B |
| YoY Revenue Growth % | +5.6% | -8.5% | — |
| Gross Profit | $427.0M | $435.1M | — |
| Gross Margin % | 22.8% | 24.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$85.5M | $64.8M | $18.1M |
| Operating Margin % | -4.6% | 3.7% | 0.9% |
| Net Income (GAAP) | -$114.6M | -$5.7M | -$38.6M |
| EBITDA (Normalized) | -$75.8M | $85.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $91.8M | $34.8M | -$129.8M |
| Capital Expenditures (CapEx) | $12.0M | $25.9M | — |
| Free Cash Flow (FCF) | $79.7M | $8.9M | -$129.8M |
| FCF Margin % | 4.3% | 0.5% | -6.7% |
| Return on Invested Capital (ROIC %) | -11.2% | 6.7% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $325.8M | $412.6M | — |
| Total Stockholders' Equity | $277.5M | $354.8M | — |